Adtalem Global Education (NYSE:CVSA – Get Free Report) was downgraded by equities researchers at Truist Financial from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, MarketBeat Ratings reports. They currently have a $140.00 target price on the stock. Truist Financial’s price target would suggest a potential upside of 4.03% from the company’s previous close.
A number of other research analysts also recently commented on CVSA. Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Wednesday, August 19th. Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Finally, Barrington Research reissued an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a research note on Monday, June 8th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $155.00.
View Our Latest Report on CVSA
Adtalem Global Education Trading Up 0.7%
Adtalem Global Education (NYSE:CVSA – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The firm had revenue of $501.38 million during the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. On average, equities analysts forecast that Adtalem Global Education will post 9 earnings per share for the current fiscal year.
Insider Buying and Selling at Adtalem Global Education
In other Adtalem Global Education news, CAO Manjunath Gangadharan sold 1,802 shares of the stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $137.18, for a total transaction of $247,198.36. Following the transaction, the chief accounting officer directly owned 5,083 shares of the company’s stock, valued at $697,285.94. This represents a 26.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert J. Phelan sold 2,186 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of $135.15, for a total transaction of $295,437.90. Following the transaction, the chief financial officer directly owned 48,306 shares in the company, valued at $6,528,555.90. The trade was a 4.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 27,753 shares of company stock valued at $3,717,982. Company insiders own 2.50% of the company’s stock.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management bought a new position in Adtalem Global Education Inc. (NYSE:CVSA – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors.
About Adtalem Global Education
Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.
Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.
Further Reading
- Five stocks we like better than Adtalem Global Education
- Enova’s Earnings Surge Meets a Valuation Test
- SLB’s Kelvion Deal Could Change How Investors Value the Oilfield Giant
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
